Clinical trial
Tamsulosin Phase III Clinical Trial -Double-Blind, Placebo Controlled Study in…
NCT00239265 · Astellas Pharma Inc, Industry · Completed
Key facts
| NCT number | NCT00239265 |
|---|---|
| Title | Tamsulosin Phase III Clinical Trial -Double-Blind, Placebo Controlled Study in Female Patients With Lower Urinary Tract Syndrome |
| Lead sponsor | Astellas Pharma Inc, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Urinary Tract Diseases |
| Intervention type | Drug |
| Interventions | Tamuslosin |
| First posted | Oct 17, 2005 |
| Last update posted | Oct 22, 2007 |
| Countries | Japan |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: